Hypertension is considered as one of the most important modifiable risk factors of cardiovascular diseases (CVD) and has a high prevalence in the community. It is characterized by having abnormally high blood pressure (
1). Hypertension is influenced by a number of factors including sex, age, race, and socio-economic status (
2). People who have hypertension have an increased risk of stroke, myocardial infarction, peripheral vascular disease, and congestive heart failure (
1). It is further thought that hypertension works in synergy and often intensifies other cardiovascular risk factors such as smoking, obesity, and diabetes mellitus (
3). The rates of hypertension in society have been on a downward trend over the last two decades; however, an increasing trend of hypertension incidences in middle and low income countries is reported (
2,
4) It is estimated that two-thirds of hypertension cases are found in developing countries (
5). Iran is one such developing country. It is located in the Middle East and is home to different people and ethnicities. A systematic review of published hypertension studies in Iran found that 22.1% of people were hypertensive, which was lower than countries such as the United States (30.4%), China (40%), Oman (53%), United Arab Emirates (50%), Qatar (49%), Bahrain (60%), and Yemen (33%), but the prevalence is going to be similar with them (
2,
6-
8). Some studies indicated that there was considerable variation in the prevalence of hypertension between different ethnic groups and across different geographic locations within Iran with some studies indicating that the North-West regions of the country had a higher prevalence of hypertension (
9). Due to the low awareness of hypertension in these societies and the asymptomatic nature of hypertension, it is not surprising that a large proportion of patients with hypertension are unaware of their condition. This unawareness is not limited to the developing countries. A study on adults older than 18 years in the United States in 2003 - 2010 found that 39.4% of patients with hypertension were not aware of their disease (
6). Moreover, a study in China found that more than 40% of the patients with hypertension were unaware of their disease (
8). The Iranian National Household Survey revealed that only 34% of people were aware of their disease (
10). However, big cities such as Tehran (50%) and Isfahan (43.8%) showcased slightly higher rates of awareness (
11,
12). The unawareness of this prominent and life-threatening disease in society is gravely concerning and could lead to serious health outcomes. It should also be noted that being aware of the disease does not necessarily guarantee a better health outcome or quality of life. Alarmingly, only between one-fourth and half of people who are aware of their hypertension receive appropriate medical treatment (
6,
8,
13). This is quite concerning, as appropriate management of hypertension can considerably reduce the risk of stroke and decrease mortality rate (
13). There are several methods for reducing undiagnosed hypertension cases. First, screening could be performed by healthcare facilities; however, it is associated with high cost and could potentially reduce feasibility in lower socio-economic regions of society such as the rural areas. A second option may be implementing door-to-door screening, but it is also associated with high cost. The third and final alternative is based on non-medical volunteers participation, as main component of clinical governance (
14), to introduce self-measurement of hypertension at home (
15). The previous studies on this issue have highlighted that the final option, to do with self-management, would be the most effective, feasible, and accessible option (
16,
17). Nongovernmental Organizations (NGOs) seem to be useful in promoting awareness in targeted populations (
18).